Clinical trial
A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in…
NCT00454350 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00454350 |
|---|---|
| Title | A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis |
| Official title | A Randomized , Open-Label, Cross-over, Pharmacokinetic Study of Doxercalciferol and Paricalcitol Following Multiple Intravenous Injections in Chronic Kidney Disease Subjects on Hemodialysis |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | Hectorol (doxercalciferol injection), Zemplar (Paricalcitol injection) |
| Enrollment | 12 |
| Start date | Feb 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Mar 30, 2007 |
| Last update posted | May 5, 2015 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: